Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
Br J Cancer. 2023 Jun;128(12):2175-2185. doi: 10.1038/s41416-023-02235-9. Epub 2023 Apr 4.
Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates in non-lymphoid tissues, which are associated with improved prognosis in some cancer types. This study aimed to investigate the clinical significance of TLSs in oesophageal cancer (EC).
In a series of 316 EC surgical specimens from two different institutes, we evaluated the density and maturity of peritumoral TLSs using haematoxylin/eosin, immunohistochemistry, and multiplex immunofluorescence staining. We analysed the association between TLSs and clinicopathological parameters. The clinical significance of TLSs was further evaluated in a different cohort of 34 patients with recurrent EC treated with anti-PD-1 antibody.
Tumours with high TLS density predominantly consisted of matured TLSs. High TLS density was significantly associated with less advanced tumour stage, absence of lymphatic/vascular invasion, better serum nutrition parameters (neutrophils count, albumin, neutrophil-to-lymphocyte ratio, and prognostic nutritional index), and prolonged survival. This survival trend was more remarkable in cases with matured TLSs, which represented an increased population of CD138 plasma cells. In the second EC cohort, TLS density predicted the clinical response to anti-PD-1 antibody and patient survival.
The density and maturity of peritumoral TLSs are useful parameters for predicting long-term survival and response to anti-PD-1 antibody treatment in EC patients.
三级淋巴结构(TLSs)是无淋巴组织中的异位淋巴聚集,与某些癌症类型的预后改善相关。本研究旨在探讨 TLSs 在食管癌(EC)中的临床意义。
在来自两个不同机构的 316 例 EC 手术标本系列中,我们使用苏木精/伊红、免疫组织化学和多重免疫荧光染色评估肿瘤周围 TLSs 的密度和成熟度。我们分析了 TLSs 与临床病理参数之间的关联。在另一组 34 例接受抗 PD-1 抗体治疗的复发性 EC 患者中,进一步评估了 TLSs 的临床意义。
高 TLS 密度的肿瘤主要由成熟的 TLSs 组成。高 TLS 密度与较不先进的肿瘤分期、无淋巴/血管侵犯、更好的血清营养参数(中性粒细胞计数、白蛋白、中性粒细胞与淋巴细胞比值和预后营养指数)以及更长的生存时间显著相关。在具有成熟 TLSs 的情况下,这种生存趋势更为明显,代表 CD138 浆细胞的增加。在第二个 EC 队列中,TLS 密度预测了对抗 PD-1 抗体的临床反应和患者的生存。
肿瘤周围 TLSs 的密度和成熟度是预测 EC 患者长期生存和对抗 PD-1 抗体治疗反应的有用参数。